Summit Healthcare Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $200.00M
IPO Date Jun 9, 2021
CEO Bo Tan
Left Lead BofA Securities
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare in Asia

IPO Geography Asia
Target Company YS Biopharma
Deal Announced Sep 29, 2022
Deal Size, $M $849.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Mar 14, 2023
Amendment Vote TBD
Closing Date Mar 16, 2023
Formerly SMIH YS YSBPW

Sign up for Free Trial

No credit card required

Sign in for more on Summit Healthcare Acquisition Corp.:

  • Structure and cap table
  • 5 directors & officers
  • 16 filings and events
  • 2 underwriters
  • 5 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Bo Tan 47 CEO, Co-CIO & Director
Ken Poon 54 President, Co-CIO & Director
Ian Stone 70 Director
Thomas Folinsbee 53 Director
Tao Bai 56 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
BofA Securities BR 19,500,000 units
Futu Securities 500,000
20,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 16 filings.

Shareholders

Sign in to view shareholders 13F filing data.